p53 Correlation with Triple-negative Breast Cancer and Potential Treatments
Abstract: Triple-negative breast cancer (TNBC) poses significant challenges in the field of oncology due to its prevalence and difficulty in treatment. TP53, which codes for a tumor-suppressing transcription factor p53, is crucial for the prevention of tumor development. When mutated, its role is reversed, as mutp53 provides new oncogenic properties and is correlated with the onset of cancers. Studies have presented a strong correlation between mutp53 and TNBC tumorigenesis by providing metastatic …
Read More
